Bank Of Montreal Ionis Pharmaceuticals Inc Call Options Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	BUY	$42.03 - $53.55 $5.46 Million - $6.96 Million	130,000 New	130,000 $5.64 Million
Q2 2023 Aug 02, 2023	SELL	$34.73 - $43.33 $732,802 - $914,263	-21,100 Reduced 26.68%	58,000 $2.38 Million
Q1 2023 Jun 13, 2024	SELL	$33.58 - $41.2 $2.01 Million - $2.47 Million	-60,000 Reduced 46.15%	70,000 $2.5 Million
Q4 2022 Feb 01, 2023	BUY	$37.12 - $46.52 $627,328 - $786,188	16,900 Added 27.17%	79,100 $2.99 Million
Q3 2022 Nov 10, 2022	BUY	$36.54 - $48.66 $2.27 Million - $3.03 Million	62,200 New	62,200 $2.91 Million

404

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.02B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.